Navigation Links
Novel therapeutic agents provide hope for patients with hard-to-treat blood disorders
Date:12/9/2012

percent CRc rate (3% CR, 3% CRp, and 29% CRi) with a median duration of response of five weeks and median overall survival of 25.6 weeks. Of those patients in both cohorts who did not respond to their last AML therapy, 47 percent of those with FLT3-ITD and 31 percent of those without achieved a CRc with quizartinib. In both cohorts, 34 percent of patients were successfully bridged to a potentially curative allogeneic transplant.

Common adverse effects of treatment with quizartinib (observed in more than 20% of patients) included QT prolongation (26%), a heart complication associated with some medications and managed by reducing dosage, as well as nausea (38%), vomiting (26%), anemia (29%), fever (25%), diarrhea (20%), and fatigue (20%). These results demonstrate that quizartinib can produce a high treatment response rate in a group of very poor-prognosis AML patients with the FLT3-ITD mutation with manageable toxicity.

"Quizartinib is the first and only single-agent drug that has produced a clinical benefit in AML patients with this deadly mutation who have failed previous therapy," said Dr. Levis. "The number of patients bridged to a stem cell transplant was very significant. We plan on using these encouraging results to design and conduct additional randomized trials that will hopefully lead to the approval of quizartinib to make it accessible to those patients who previously had no hope for a cure."

Dr. Levis will present this study in an oral presentation on Monday, December 10, at 4:30 p.m. EST at the Georgia World Congress Center in Room A101, Level 1, Building A.

Combination Therapy Using JAK2 and HSP90 Inhibitors Increased Efficacy in Myelofibrosis in Vivo [Abstract 805]

Researchers have demonstrated that combination therapy with PU-H71 and ruxolitinib increases the durability and effectiveness of a treatment t
'/>"/>

Contact: Andrea Slesinski
aslesinski@hematology.org
614-352-5096
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Researchers develop novel 3-D culture system for inflammatory breast cancer
2. ACNP: Novel NMDA receptor modulator significantly reduces depression scores within hours
3. Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
4. Novel mechanism through which normal stromal cells become cancer-promoting cells identified
5. Novel breast screening technology increases diagnostic accuracy
6. UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
7. Moffitt Cancer Center researchers identify novel metabolic programs driving aggressive brain tumors
8. Novel treatment strategies for epilepsy
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Researchers ID potential patient population who may benefit from novel anti-platelet treatment
11. Undertreatment of common heart condition persists despite rapid adoption of novel therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... India (PRWEB) July 31, 2014 ... Marketing Company, has introduced a new service named ... , Ethane Web Technologies has designed the service ... of clients and Java Development service being provided ... the company a confidence to promise outstanding Java ...
(Date:7/31/2014)... human body contains a unique protein that has the unusual ... - it must therefore be continually recreated and is no ... including the dissolving of coagulated blood. If you get a ... a clot has accumulated in a blood vessel, and therefore ... in general and for helping people with a blood clot ...
(Date:7/31/2014)... 2014 Healthinsurancefacts.org has released a ... insurance plans by comparing quotes. , In order ... should consider comparing quotes. They can do this by ... simple questionnaire. , Clients should do proper research ... health insurance policies, and each of them can be ...
(Date:7/31/2014)... July 31, 2014 The National ... event in New York on Thursday, August 7, from ... , Featuring keynotes by State Senator Diane J. ... the event will include lunch and in-depth discussions on ... the work NCIA is doing federally to advance a ...
(Date:7/31/2014)... Beverly Hills, CA (PRWEB) July 31, 2014 ... president George W. Bush recently underwent partial knee replacement surgery ... right knee less than two months earlier. The story also ... between the procedures and hopes to be back on the ... replacement surgery highlights the benefits of partial knee replacement. ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Breakthrough in understanding of important blood protein 2Health News:Breakthrough in understanding of important blood protein 3Health News:Comparing Health Insurance Quotes Can Help Clients Find Affordable Plans 2Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2
... Kay Warren and Other Leaders ... Church-Based Strategy, LAKE FOREST, Calif., Nov. 29 Dr. Rick ... & The Church by,challenging attendees on the desperate need for leaders ... have AIDS?, -- but that is the,wrong question; rather, we should ...
... for filing the New,Drug Application (NDA) for the use of lacosamide ... ... UCB announced today that the U.S. Food,and Drug Administration (FDA) has ... lacosamide in the treatment of diabetic,neuropathic pain. The application relates to ...
... Inc. (Nasdaq: MITI ) and MedImmune, Inc. today ... trial of MT103 in patients with late-,stage non-Hodgkin,s lymphoma ... the American Society of Hematology (ASH) on December 9 ... recombinant T-cell,engaging antibody, or BiTE(R) antibody, targeting the CD19 ...
... Nov. 29 MedCath Corporation,(Nasdaq: MDTH ) announced ... BMO Capital Markets 2007 Focus on Healthcare Conference,held Dec. ... in New York., MedCath,s senior management will give ... ET. The presentation will be web cast live over ...
... November 29 InSightec Ltd. today,reported that it has ... its existing investors: Elbit Imaging Ltd. (Nasdaq: EMITF ... Electric Company,(NYSE: GE ), MediTech Advisors LLC ("MTA"), ... and managers of the company., The investment will ...
... ... HOOFDDORP, The Netherlands, November 29 CEVA Group Plc,released its Quarter ... - First presentation of results following the EGL acquisition on ... million in Q3 2006, - Adjusted EBITDA improved to EUR93.1million ...
Cached Medicine News:Health News:Third Annual Saddleback Global Summit on AIDS & The Church Focuses on Cooperative Leadership: 2Health News:Third Annual Saddleback Global Summit on AIDS & The Church Focuses on Cooperative Leadership: 3Health News:UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 2Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 3Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 4Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 5Health News:Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkin's Lymphoma Patients 6Health News:InSightec Ltd. Announces US$30 Million Investment Round 2Health News:InSightec Ltd. Announces US$30 Million Investment Round 3Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 2Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 3Health News:CEVA Group Plc Reports Quarter 3, 2007 Results 4
(Date:7/31/2014)... -- Endo International plc (NASDAQ: ENDP ) ... $719 million, an increase of 1 percent compared to ... net income of $21 million in the second quarter ... the second quarter of 2013.  As detailed in the ... three months ended June 30, 2014 increased by 4 percent ...
(Date:7/31/2014)... Pa. , July 31, 2014 ... AUXL ), a specialty biopharmaceutical company, today announced ... regulatory milestone payment from its partner Asahi Kasei ... because of the successful submission of a regulatory ... Agency (PMDA) for XIAFLEX ® (collagenase clostridium ...
(Date:7/30/2014)... , July 30, 2014 Advanced Photonix ® ... (ending June 27, 2014) financial results on Monday, August 11, ... released after the close of the market and the Company ... results at 4:30 p.m. EDT on the same day. ... (CEO and Director), Rob Risser (COO and ...
Breaking Medicine Technology:Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Healthcare Conference on Friday, September 17, 2010 at 8:35 a.m. ... the Four Seasons in Boston.  Steve Worland, Ph.D., President and ... Anadys and its clinical development programs. Dr. Worland ...
... SYK ) announced that it will host a ... Eastern Time, to discuss the Company,s operating results for the ... Operating results for the quarter ended September 30, 2010 will ... participate in the conference call dial 866-270-6057(domestic) or ...
Cached Medicine Technology:Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2Stryker to Host Conference Call on October 19, 2010 2
... 55S Rocking Shaker provides the exact ... membranes. The very slow to fast ... tilt provide a gentle wave motion ... and blotted membranes to achieve faster, ...
Conversion Kits For Modular Incubator Chamber...
Inquire...
Inquire...
Medicine Products: